Fountain Healthcare Partners
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Seed, Early Stage, Growth, Late Stage, Pre-IPO
Geographical Focus
United States, United Kingdom, Germany, France, Italy, Denmark, Switzerland, Spain, Ireland, Austria, Netherlands, Hungary, Sweden, Belgium, Norway, Finland, Poland, Czech Republic, Romania, Bulgaria
Industries Focus
- Healthcare
- HealthTech
- Life Sciences
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Medtech
- Biotechnology
- Clinical Trials
- Regenerative Medicine
- Immuno-Oncology
- Medical Technology
- Healthcare IT
- Biopharmaceuticals
- Cell Therapy
- Gene Therapy
- Specialty Pharma
- Pharmaceutical Research
Investment Size:
10,000,000 to 15,000,000 USD
Investor Details Founded: 2008
Fountain Healthcare Partners is a life science venture capital firm with offices in Dublin, Ireland, and New York, USA. Founded in 2008, it is Ireland's largest dedicated life science venture capital fund, managing over €300 million in assets. The firm focuses on investing in entrepreneurs and companies with disruptive technologies or products that offer clear pharmacoeconomic benefits and defined pathways to commercialization, value enhancement, and exit. Fountain typically leads or co-leads its investments, sourcing deals from start-ups, corporate spin-outs, and turnaround situations.
The firm's investment strategy encompasses a broad spectrum of stages, from seed to pre-IPO, and spans various sectors within the life sciences, including biotechnology, medical devices, specialty pharmaceuticals, diagnostics, and biopharmaceuticals. Fountain deploys the majority of its capital in Europe, with the remainder in the United States, bridging the continents to facilitate partnerships and build international networks for its portfolio companies.
With over 70 years of collective experience in the pharmaceutical industry, corporate venture capital, and venture capital across multiple investment and market cycles, the firm's principals—Manus Rogan, Aidan King, and Ena Prosser—bring extensive expertise to their investees. Fountain Healthcare Partners is committed to responsible investment, aiming to provide more than just capital by offering strategic guidance and support to its portfolio companies, helping them grow smartly, mitigate risk, and expand their impact.
Requirements
- Disruptive technologies or products with clear pharmacoeconomic benefits
- Defined pathway to commercialization, value enhancement, and exit
- Potential for a strong exit within 4 to 6 years
- Alignment with Fountain's sectors of interest: biotechnology, medical devices, specialty pharmaceuticals, diagnostics, biopharmaceuticals
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Calypso Biotech
- Ermium Therapeutics
- Kurma Partners
- Kyowa Kirin Co., Ltd.
Mentioned In
-
$24.95
-
$49.95
-
$39.95
-
$19.95
-
$24.95
-
$99.00
-
$245.00
Claim this Investor
Are you an official representative of Fountain Healthcare Partners?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim